| Literature DB >> 35916720 |
Carolina Wannheden1, Matilda Åberg-Wennerholm1, Marie Dahlberg1, Åsa Revenäs1,2,3, Sara Tolf1, Elena Eftimovska1, Mats Brommels1.
Abstract
BACKGROUND: An increasing number of patients expect and want to play a greater role in their treatment and care decisions. This emphasizes the need to adopt collaborative health care practices, which implies collaboration among interprofessional health care teams and patients, their families, caregivers, and communities. In recent years, digital health technologies that support self-care and collaboration between the community and health care providers (ie, participatory health technologies) have received increasing attention. However, knowledge regarding the features of such technologies that support effective patient-professional partnerships is still limited.Entities:
Keywords: chronic disease; cocare; collaborative care; digital health; eHealth; long-term conditions; mobile phone; participatory health; participatory health informatics; partnership care management; scoping review
Mesh:
Year: 2022 PMID: 35916720 PMCID: PMC9379797 DOI: 10.2196/38980
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 7.076
Inclusion and exclusion criteria.
| Criteria | Inclusion | Exclusion | |
| Type of studies | Qualitative, quantitative, and mixed methods studies on the phenomenon published in peer-reviewed journals | Letters, commentaries, editorials, conference abstracts, doctoral theses, or any type of review | |
| Period | January 1, 2008, until December 14, 2020 | Before January 1, 2008, and after December 14, 2020 | |
| Language | English and Swedish | All other languages | |
| Type of participants | Patients with chronic conditions, defined as a health condition that lasts at least 3 months | Patients who do not have chronic conditions | |
|
| Studies that meet all 3 criteria listed below | Studies that do not meet all the 3 criteria listed below | |
|
| Digital health technology | A digital health technology is defined as software intended for use for | Nondigital services or digital services not specifically intended for medical use; for example, WhatsApp, email, telephone, and SMS text messages are technologies that are not primarily intended for the abovementioned purposes and were thus excluded |
|
| Partnership | The digital health technology intends to support collaboration and enables interaction between at least two types of users: patients or caregivers, and health care professionals or allied professionals (eg, pharmacists) | Digital health services for peer-to-peer collaboration between patients or caregivers only, or tools for team collaboration among staff, without patient or caregiver involvement, were excluded; tools that only intended to support self-care or treatment adherence were also excluded |
|
| Evaluation | Evaluation results testing the digital health technology in chronic care need to be available | Studies that merely describe the design and development of digital health technologies; evaluation that has not been performed in a real-world setting (eg, heuristic evaluation by experts) |
Figure 1PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow chart.
Figure 2Number of included papers by year and world region.
Context of use.
| Characteristic | References | ||
|
| |||
|
| Primary care | [ | |
|
| Secondary care | [ | |
|
| Tertiary care | [ | |
|
| |||
|
| Metabolic (diabetes) | [ | |
|
| Cardiovascular | [ | |
|
| Autoimmune | [ | |
|
| Pulmonary | [ | |
|
| Cancer | [ | |
|
| Genetic | [ | |
|
| Immunodeficiency | [ | |
|
| Psychiatric | [ | |
|
| Neurodegenerative | [ | |
|
| Unspecified | [ | |
Study designs and outcomes.
| Characteristic | References | ||
|
| |||
|
| Design and implementation | [ | |
|
| User experiences | [ | |
|
| Feasibility | [ | |
|
| Effects | [ | |
|
| |||
|
| Randomized controlled trial | [ | |
|
| Quantitative | [ | |
|
| Qualitative | [ | |
|
| Mixed methods | [ | |
|
| |||
|
| ≤50 | [ | |
|
| 51-100 | [ | |
|
| 101-150 | [ | |
|
| 151-200 | [ | |
|
| >200 | [ | |
|
| |||
|
| Clinical outcomes | [ | |
|
| Partnership | [ | |
|
| Self-management | [ | |
|
| User experiences | [ | |
|
| |||
|
| Positive outcomes | [ | |
|
| Mixed results | [ | |
|
| No change | [ | |
|
| N/Aa | [ | |
aN/A: not applicable.
Thematic analysis of participatory health technology features.
| Themes (features) | References | ||
|
| |||
|
| Asynchronous message exchange | [ | |
|
| Audio or video communication | [ | |
|
| Unspecified | [ | |
|
| |||
|
| Self-measurements of health parameters | [ | |
|
| Self-assessment of symptoms or problems | [ | |
|
| Self-reported health status or activity | [ | |
|
| Self-reported medication adherence or side effects | [ | |
|
| Diary for personal notes | [ | |
|
| |||
|
| Personalized goals | [ | |
|
| Medication management | [ | |
|
| Individual feedback | [ | |
|
| Tailored recommendations | [ | |
|
| Alerts and reminders or prompts | [ | |
|
| |||
|
| Educational material integrated in participatory health technology | [ | |
|
| Links to external sources | [ | |
|
| |||
|
| Access to a personal care plan | [ | |
|
| Appointments and previsit planning | [ | |
|
| |||
|
| Anonymous contributions | [ | |
|
| Health care professional monitored | [ | |
|
| Unspecified | [ | |
Figure 3Illustration of identified participatory health technology features in each of the included papers, grouped by the total number of features (ranging from 1 to 5) [32-65].